Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) EBT Margin (2019 - 2023)

Historic EBT Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 65114.29%.

  • Benitec Biopharma's EBT Margin changed N/A to 65114.29% in Q2 2023 from the same period last year, while for Mar 2024 it was 307371.43%, marking a year-over-year decrease of 2789831900.0%. This contributed to the annual value of 25485.33% for FY2023, which is 9839600.0% down from last year.
  • Per Benitec Biopharma's latest filing, its EBT Margin stood at 65114.29% for Q2 2023.
  • Benitec Biopharma's 5-year EBT Margin high stood at 8220.0% for Q2 2020, and its period low was 379500.0% during Q1 2021.
  • Its 5-year average for EBT Margin is 80666.78%, with a median of 8051.85% in 2023.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by 2000000000bps in 2021, then soared by 2000000000bps in 2022.
  • Quarter analysis of 5 years shows Benitec Biopharma's EBT Margin stood at 2719.48% in 2019, then crashed by -11891bps to 326100.0% in 2020, then surged by 94bps to 19384.0% in 2021, then crashed by -107bps to 40135.71% in 2022, then plummeted by -62bps to 65114.29% in 2023.
  • Its last three reported values are 65114.29% in Q2 2023, 8051.85% for Q1 2023, and 40135.71% during Q4 2022.